Skip to main navigation Skip to search Skip to main content

An 8 Week Open Label Study to Evaluate the Efficacy and Safety of Acamprostate Calcium (Camprall) as Augmentation Therapy in Patients with Anxiety Symptoms Who are Only Partial Responders to SSRI's

Project: Research

Project Details

StatusFinished
Effective start/end date07/10/0603/31/10

Funding

  • Forest Research Institute: $32,275.75